epilepsy market in the us 2015-2019
TRANSCRIPT
Covered in This Report
• The Epilepsy market in the US can be divided into three segments: First-generation Drugs, Second-generation Drugs, and Third-generation Drugs.
• This report covers the present scenario and the growth prospects of the Epilepsy market in the US for the period 2015-2019.
• To calculate the market size, the report considers the revenue generated through the sales of anti-epileptic drugs approved in the US to treat the symptoms of epilepsy.
• TechNavio's report, Epilepsy Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.
• The report covers the landscape of the Epilepsy Market in the US and its growth prospects in the coming years.
• The report also includes a discussion of the key vendors operating in this market.
Phone: + 44 208 123 1770 [email protected]
Market Overview
• Epilepsy is a spectrum of brain disorders varying from benign to severe, disabling,and life-threatening symptoms.
• It is caused by various factors ranging from brain malformations and tumors tomeningitis, high-risk pregnancies, and birth trauma.
• However, when the underlying cause of the disease is unidentified, as in themajority of the cases, it is known as idiopathic epilepsy.
• Epilepsy is characterized by repeated occurrence of generalized or focal seizures.
• An imbalance between the inhibitory and excitatory signals of the brain, leadingto a sudden onset of excitation, results in seizures.
• Occurrence of two or more unprovoked seizures is an important criterion todiagnose a person as being epileptic.
• TechNavio's analysts forecast the Epilepsy market in the US to grow at a CAGR of4.85 percent over the period 2014-2019.
For more information on the
Epilepsy Market in the US 2015-2019,
please mail us [email protected]
Key Regions
• US
A detailed analysis of each market driver, challenge and trend is available
in our report:
Ask an AnalystOr
Inform us by e-mailing [email protected]
Vendors
• GlaxoSmithKline
• Pfizer
• UCB
Key Vendors
Vendors
• Abbvie
• Eisai
• F. Hoffmann-La Roche
• H. Lundbeck
• Janssen Pharmaceuticals
• Meda AB
• Novartis
• For a full, detailed list, view our report
Other Prominent Vendors
Key Questions Answered in Our Report
• What will the market size be in 2019 and what will the growth ratebe?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the keyvendors?
• What are the strengths and weaknesses of the key vendors?
View Our Report
Epilepsy Market in the US 2015-2019
68 Pages | SKU: IRTNTR5028
View Report >>
